Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 May 6;7(6):1161-1166.
doi: 10.1002/ccr3.2176. eCollection 2019 Jun.

Variant form of hairy cell leukemia

Affiliations
Case Reports

Variant form of hairy cell leukemia

Margaux Wiber et al. Clin Case Rep. .

Abstract

Mature lymphoid B-cell proliferations with hairy cells represent heterogeneous entities where specific diagnosis is difficult but important since it impacts therapeutic management. The clinical cases of variant hairy cell leukemia reported herein illustrate the persistence of a clear interest in the use of splenectomy as a therapeutic alternative. Furthermore, ibrutinib appears to be a promising treatment in patients with relapsed/refractory disease.

Keywords: BRAFV600E; Ibrutinib; KDM6A; chronic B‐lymphoproliferative disorder; hairy cell leukemia; hairy cell leukemia variant.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Case 1. A, Hairy cells in peripheral blood. B, Hairy cells in bone marrow. C, Flow cytometric analysis of expression levels of CD103, CD123, CD25, and CD11c (HCL score) on hairy cells. D, Complete blood count evolution. C, cladribine; R, rituximab
Figure 2
Figure 2
Case 2. A, Hairy cells in peripheral blood. B, Hairy cells in bone marrow. C, Flow cytometric analysis of expression levels of CD103, CD123, CD25, and CD11c (HCL score) on hairy cells. D, Complete blood count evolution

References

    1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375‐2390. - PMC - PubMed
    1. Matutes E. Immunophenotyping and differential diagnosis of hairy cell leukemia. Hematol Oncol Clin North Am. 2006;20(5):1051‐1063. - PubMed
    1. Waterfall JJ, Arons E, Walker RL, et al. High prevalence of MAP2K1 mutations in variant and IGHV4‐34‐expressing hairy‐cell leukemias. Nat Genet. 2014;46(1):8‐10. - PMC - PubMed
    1. Robak T, Matutes E, Catovsky D, Zinzani PL, Buske C. Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Ann Oncol. 2015;26(suppl 5):v100‐v107. - PubMed
    1. Troussard X, Cornet E. Proliférations lymphoïdes B matures à cellules chevelues. Ann Biol Clin. 2015;73(4):399‐406. - PubMed

Publication types

LinkOut - more resources